341 related articles for article (PubMed ID: 32730855)
1. Transcription factor NRF2 as a promising therapeutic target for Alzheimer's disease.
Qu Z; Sun J; Zhang W; Yu J; Zhuang C
Free Radic Biol Med; 2020 Nov; 159():87-102. PubMed ID: 32730855
[TBL] [Abstract][Full Text] [Related]
2. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Approaches to Alzheimer's Disease Through Modulation of NRF2.
Bahn G; Jo DG
Neuromolecular Med; 2019 Mar; 21(1):1-11. PubMed ID: 30617737
[TBL] [Abstract][Full Text] [Related]
4. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
[TBL] [Abstract][Full Text] [Related]
6. The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities.
De Plano LM; Calabrese G; Rizzo MG; Oddo S; Caccamo A
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979483
[TBL] [Abstract][Full Text] [Related]
7. Nrf2: a dark horse in Alzheimer's disease treatment.
Osama A; Zhang J; Yao J; Yao X; Fang J
Ageing Res Rev; 2020 Dec; 64():101206. PubMed ID: 33144124
[TBL] [Abstract][Full Text] [Related]
8. Natural antioxidants that act against Alzheimer's disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action.
Sidiropoulou GA; Metaxas A; Kourti M
Front Endocrinol (Lausanne); 2023; 14():1217730. PubMed ID: 37465125
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modification of Nrf2 by sulforaphane increases the antioxidative and anti-inflammatory capacity in a cellular model of Alzheimer's disease.
Zhao F; Zhang J; Chang N
Eur J Pharmacol; 2018 Apr; 824():1-10. PubMed ID: 29382536
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review.
Fakhri S; Pesce M; Patruno A; Moradi SZ; Iranpanah A; Farzaei MH; Sobarzo-Sánchez E
Molecules; 2020 Oct; 25(21):. PubMed ID: 33114450
[TBL] [Abstract][Full Text] [Related]
11. Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer's Disease?
Murphy KE; Park JJ
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561773
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 Suppresses Oxidative Stress and Inflammation in
Uruno A; Matsumaru D; Ryoke R; Saito R; Kadoguchi S; Saigusa D; Saito T; Saido TC; Kawashima R; Yamamoto M
Mol Cell Biol; 2020 Feb; 40(6):. PubMed ID: 31932477
[TBL] [Abstract][Full Text] [Related]
13. Slingshot homolog-1-mediated Nrf2 sequestration tips the balance from neuroprotection to neurodegeneration in Alzheimer's disease.
Cazzaro S; Woo JA; Wang X; Liu T; Rego S; Kee TR; Koh Y; Vázquez-Rosa E; Pieper AA; Kang DE
Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2217128120. PubMed ID: 37463212
[TBL] [Abstract][Full Text] [Related]
14. Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease.
Kaundal RK; Datusalia AK; Sharma SS
Pharmacol Res; 2022 Jan; 175():106018. PubMed ID: 34863823
[TBL] [Abstract][Full Text] [Related]
15. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases.
George M; Tharakan M; Culberson J; Reddy AP; Reddy PH
Ageing Res Rev; 2022 Dec; 82():101756. PubMed ID: 36243357
[TBL] [Abstract][Full Text] [Related]
16. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of early upstream events in prodromal Alzheimer's disease by use of targeted antioxidants.
Prasad KN; Bondy SC
Curr Aging Sci; 2014; 7(2):77-90. PubMed ID: 25101711
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases.
Bai X; Bian Z; Zhang M
Phytomedicine; 2023 Jan; 109():154582. PubMed ID: 36610130
[TBL] [Abstract][Full Text] [Related]
19. Increases of iASPP-Keap1 interaction mediated by syringin enhance synaptic plasticity and rescue cognitive impairments via stabilizing Nrf2 in Alzheimer's models.
Wang CY; Zhang Q; Xun Z; Yuan L; Li R; Li X; Tian SY; Xin N; Xu Y
Redox Biol; 2020 Sep; 36():101672. PubMed ID: 32828017
[TBL] [Abstract][Full Text] [Related]
20. Conjugated linoleic acid downregulates Alzheimer's hallmarks in aluminum mouse model through an Nrf2-mediated adaptive response and increases brain glucose transporter levels.
Cuciniello R; Luongo D; Ferramosca A; Lunetti P; Rotondi-Aufiero V; Crispi S; Zara V; Maurano F; Filosa S; Bergamo P
Free Radic Biol Med; 2022 Oct; 191():48-58. PubMed ID: 36028179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
